marketcap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
Zynex Market Cap 2011-2025 | ZYXI
As of November 06, 2025 Zynex has a market cap of $ 34.5 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Zynex
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 80.8 M | 448 M | 485 M | 268 M | 607 M | 316 M | 125 M | 151 M | 9.13 M | 10 M | 5.47 M | 6.27 M | 10.5 M | 11.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 607 M | 5.47 M | 181 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Dynatronics Corporation
DYNT
|
1.95 M | $ 0.24 | 14.99 % | $ 929 K |  USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | $ 1.48 | 1.37 % | $ 20.5 M | USA |
 |
Natus Medical Incorporated
NTUS
|
799 M | $ 31.08 | 1.94 % | $ 1.05 B | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | $ 9.22 | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | $ 3.05 | -5.86 % | $ 30.6 M | USA |
 |
Cardiovascular Systems
CSII
|
588 M | $ 20.0 | 0.15 % | $ 844 M | USA |
 |
Neovasc
NVCN
|
677 M | $ 30.03 | - | $ 111 M |  Canada |
 |
Apollo Endosurgery
APEN
|
403 M | $ 10.0 | - | $ 475 M | USA |
 |
Titan Medical
TMDI
|
115 M | $ 0.14 | -26.32 % | $ 19.6 M | Canada |
 |
OrthoPediatrics Corp.
KIDS
|
589 M | $ 16.3 | -0.46 % | $ 376 M | USA |
 |
Medtronic PLC
MDT
|
111 B | $ 90.01 | -0.45 % | $ 116 B | USA |
 |
Viveve Medical
VIVE
|
10.1 M | $ 0.22 | -15.35 % | $ 1.71 M | USA |
 |
Myomo
MYO
|
5.64 M | $ 0.83 | -3.42 % | $ 5.85 M | USA |
 |
Invacare Corporation
IVC
|
24.1 M | $ 0.66 | - | $ 24.7 M | USA |
 |
Abiomed
ABMD
|
16.2 M | $ 381.02 | - | $ 17.2 B | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | $ 0.55 | 3.58 % | $ 2.21 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | $ 5.28 | 1.15 % | $ 34.5 M | USA |
 |
CryoLife, Inc.
CRY
|
906 M | $ 17.84 | -4.14 % | $ 702 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | $ 24.04 | - | $ 1.77 B | USA |
 |
Soliton, Inc.
SOLY
|
229 M | $ 20.12 | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | $ 10.38 | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | $ 30.65 | 0.03 % | $ 1.58 B |  Israel |
 |
FONAR Corporation
FONR
|
85.2 M | $ 14.9 | 1.02 % | $ 97.7 M | USA |
 |
Misonix, Inc.
MSON
|
185 M | $ 26.54 | - | $ 462 M | USA |
 |
ShockWave Medical
SWAV
|
9.61 B | $ 334.75 | - | $ 12.3 B | USA |
 |
Quanterix Corporation
QTRX
|
893 M | $ 5.06 | -2.13 % | $ 190 M | USA |
 |
AVITA Medical
RCEL
|
229 M | $ 3.41 | -2.57 % | $ 88.3 M |  Australia |
 |
SeaSpine Holdings Corporation
SPNE
|
403 M | $ 7.16 | 0.28 % | $ 270 M | USA |
 |
ViewRay
VRAY
|
477 M | $ 2.64 | 1.54 % | $ 468 M | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | $ 28.24 | - | $ 955 M | USA |
 |
Bruker Corporation
BRKR
|
6.9 K | $ 39.0 | -2.99 % | $ 5.81 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | $ 70.98 | - | $ 3.31 B | USA |
 |
Integer Holdings Corporation
ITGR
|
4.58 B | $ 66.7 | -2.23 % | $ 2.24 B | USA |
 |
Sintx Technologies
SINT
|
187 K | $ 3.4 | -2.02 % | $ 12.7 M | USA |
 |
BIOLASE
BIOL
|
192 K | $ 0.13 | -13.19 % | $ 166 K | USA |
 |
Eargo
EAR
|
17 M | $ 2.57 | - | $ 10.2 M | USA |
 |
Delcath Systems
DCTH
|
375 M | $ 8.51 | -1.96 % | $ 243 M | USA |
 |
SmileDirectClub
SDC
|
74 M | $ 0.08 | -53.45 % | $ 9.71 M | USA |
 |
Globus Medical
GMED
|
11.4 B | $ 61.25 | -0.44 % | $ 8.31 B | USA |
 |
ThermoGenesis Holdings
THMO
|
2.09 M | $ 0.31 | -25.84 % | $ 171 K | USA |
 |
Acutus Medical
AFIB
|
5.24 M | $ 0.09 | -26.83 % | $ 2.62 M | USA |
 |
ClearPoint Neuro
CLPT
|
466 M | $ 18.34 | 8.01 % | $ 496 M | USA |
 |
Surgalign Holdings
SRGA
|
11.4 M | $ 0.18 | -32.98 % | $ 1.68 M | USA |
 |
Conformis
CFMS
|
12.6 M | $ 2.27 | - | $ 16.4 M | USA |
 |
Sientra
SIEN
|
171 M | $ 0.18 | -16.59 % | $ 10.3 M | USA |
 |
NuVasive
NUVA
|
2.29 B | $ 39.75 | - | $ 2.07 B | USA |
 |
Cutera
CUTR
|
46.5 M | $ 0.1 | -10.19 % | $ 1.99 M | USA |
 |
Nemaura Medical
NMRD
|
24.4 M | $ 0.11 | -17.8 % | $ 2.74 M |  Britain |
 |
Vapotherm
VAPO
|
7.67 M | $ 1.27 | 6.72 % | $ 34 M | USA |
 |
Pulmonx Corporation
LUNG
|
341 M | $ 1.75 | 2.65 % | $ 68.4 M | USA |